Committee reports SB 106 as amended to tighten tianeptine product definition

Senate Bill 106 was reported as amended by the subcommittee after sponsors and counsel revised statutory language to more clearly define a 'tianeptine product' and confirm the section does not preclude prosecution under other statutes.

Committee counsel explained the amendments: remove the words 'sodium or tianeptine sulfate' from the definition so the statute covers any product marketed for human consumption that contains any amount of tianeptine; and add a subsection stating the section does not preclude prosecution under other statutes. The sponsor described the public‑health rationale: tianeptine (referred to in testimony by many as a dangerous opioid‑mimic sold at convenience stores under names like 'gas station heroin') remains available despite prior listing, and the amended language aims to hold sellers accountable and remove dangerous products from shelves.

With no in‑room opposition, the committee moved to report SB 106 as amended; the clerk opened the roll and the bill was reported as amended unanimously, 10–0.